Vanguard Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$143M Sell
2,193,550
-3,925
-0.2% -$178K ﹤0.01% 1309
2026
Q2
$62.6M Buy
2,197,475
+37,018
+2% +$806K ﹤0.01% 1810
2026
Q1
$37.5M Buy
+2,160,457
New +$40.9M ﹤0.01% 2005

Other funds holding CDNA

Vanguard Capital Management's CDNA Position: Q3 2026 in Review

Vanguard Capital Management reduced its CareDx (CDNA) stake by 0.18% in Q3 2026, selling an estimated $178K and leaving 2,193,550 shares worth $143M. The position accounts for ﹤0.01% of the portfolio, ranked #1309.

Vanguard Capital Management first reported a position in CDNA in Q1 2026 and has held it in 3 quarters since. 308 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • Vanguard Capital Management held 2,193,550 shares of CareDx worth $143M as of Q3 2026.
  • Vanguard Capital Management sold 3,925 CareDx shares in Q3 2026, an estimated $178K.
  • CareDx made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1309 holding.
  • Vanguard Capital Management first reported a position in CareDx in Q1 2026 and has held it in 3 quarters since.
  • 308 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.